title: Can ivabradine still be used in clinical practice after the 'SIGNIFY' trial?
authors.forename: Jan-Christian
authors.initials: JC
authors.lastname: Reil
authors.forename: Michael
authors.initials: M
authors.lastname: Bohm
mesh_terms: D000889:Anti-Arrhythmia Agents / Q000009:adverse effects / Q000627:therapeutic use; D001552:Benzazepines / Q000009:adverse effects / Q000627:therapeutic use*; D002317:Cardiovascular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000188:drug therapy*; D006801:Humans; D000077550:Ivabradine; D016896:Treatment Outcome
chemical_list: D000889:Anti-Arrhythmia Agents; D001552:Benzazepines; D002317:Cardiovascular Agents; D000077550:Ivabradine